Indication of PCSK9 inhibitors in the expert view of the CSAT

Publication at Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové |

2016

12 people

Abstract

Review of the use of PCSK9 mononclonal antibodies with a special emphasis on treatment allocation strategies focusin on population with familial hypercholesterolemia.

Keywords

Familial hypercholesterolemia statins PCSK9 inhibitors LDL-cholesterol

Indication of PCSK9 inhibitors in the expert view of the CSAT

Abstract

Keywords

People